[Lu-177]Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The NETTER-2 Study

Singh, S; Pavel, M; Kunz, PL; de Herder, W; Herrmann, K; D'Amelio, AM; Santoro, P; Folitar, I; Ferone, D

PANCREAS, 2022; 51 (3): E58

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索